TY - JOUR
T1 - The association of breast surgery ASPIRE
T2 - breast pain pathway rapid evaluation project - study protocol
AU - Hubbard, Thomas J E
AU - Isaac, Anna T
AU - Cui, Alice
AU - Cutress, Ramsey I
AU - Dave, Rajiv
AU - Ellis, Katy
AU - Fields, Jo
AU - Halliday, Suzanne
AU - Hu, Jennifer
AU - Potter, Shelley
AU - Chagla, Leena
AU - Cox, Karina
AU - Holcombe, Christopher
N1 - Publisher Copyright:
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - BACKGROUND: Breast pain accounts for 20-40% of new referrals to breast units in the UK and these patients have a very low risk of breast cancer. Patients have previously been assessed in resource-intensive, cancer-exclusion, one stop clinics, which are now failing to meet government targets due to excessive demand. UK Breast units are increasingly piloting Breast Pain-only Pathways (BPP) to assess these patients, and there is no consensus for the optimal pathway. The aim of this prospective multicentre study is to assess the safety and patient satisfaction of different BPPs to inform future BPP design and implementation.METHODS: All UK breast units will be invited to join the ASPIRE study between January 2023 and December 2023. Units with a BPP are invited to submit their pathway for evaluation; and those without a BPP who see patients with breast pain-only in a one stop clinics setting are also invited to join the study to evaluate the traditional pathway model concurrently. Patient satisfaction assessments will be collected after their initial consultation and patient outcomes, including subsequent cancer diagnosis, will be followed up at 12 months to determine if they have cancer diagnosis after discharge to assess pathway safety.
AB - BACKGROUND: Breast pain accounts for 20-40% of new referrals to breast units in the UK and these patients have a very low risk of breast cancer. Patients have previously been assessed in resource-intensive, cancer-exclusion, one stop clinics, which are now failing to meet government targets due to excessive demand. UK Breast units are increasingly piloting Breast Pain-only Pathways (BPP) to assess these patients, and there is no consensus for the optimal pathway. The aim of this prospective multicentre study is to assess the safety and patient satisfaction of different BPPs to inform future BPP design and implementation.METHODS: All UK breast units will be invited to join the ASPIRE study between January 2023 and December 2023. Units with a BPP are invited to submit their pathway for evaluation; and those without a BPP who see patients with breast pain-only in a one stop clinics setting are also invited to join the study to evaluate the traditional pathway model concurrently. Patient satisfaction assessments will be collected after their initial consultation and patient outcomes, including subsequent cancer diagnosis, will be followed up at 12 months to determine if they have cancer diagnosis after discharge to assess pathway safety.
U2 - 10.1097/SP9.0000000000000021
DO - 10.1097/SP9.0000000000000021
M3 - Article (Academic Journal)
C2 - 38433870
SN - 2468-3574
VL - 28
SP - 37
EP - 42
JO - International Journal of Surgery Protocols
JF - International Journal of Surgery Protocols
IS - 1
ER -
